{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-026352","form_type":"8-K","ticker":"GBCS","cik":"0000727346","company_name":"SELECTIS HEALTH, INC.","filed_at":"2022-09-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.031170+00:00","generated_at":"2026-06-23T08:39:15.201434+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Selectis Health Q2 revenue up 91% to $11.5M; net income $1.0M vs loss year ago","bullets":["Q2 2022 revenue $11.5M (record), up 91% YoY; net income $1.0M ($0.34 per share) vs net loss of $0.7M.","Q1 2022 revenue $10.1M, up 75% YoY; net income $0.2M ($0.07 per share) vs $0.2M.","Company became current on SEC filings by filing Q1 and Q2 2022 10-Qs, resolving prior delays.","Appointed Christine Lucus as CFO and David Furstenberg to board; cash $3.9M at June 30, 2022.","Operating cash flow improved to $0.1M for six months ended June 30, 2022 vs ($0.6M) year ago."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-026352","json":"https://secwatch.observer/filing/0001493152-22-026352.json","markdown":"https://secwatch.observer/filing/0001493152-22-026352.md","text":"https://secwatch.observer/filing/0001493152-22-026352.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/727346/000149315222026352/0001493152-22-026352-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/727346/000149315222026352/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T08:39:15.201434+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}